UnratedDrug recall · FDA · Published January 15, 2021
Calvin Scott Benzonatate Capsules Recall: Label Mix-Up Risk
Calvin Scott recalls 100mg Benzonatate capsules repackaged in 30-count bottles due to label mix-up with Benzphetamine tablets. Affected products contain incorrect medications.
“Calvin Scott Benzonatate Capsules Recall: Label Mix-Up Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36550-calvin-scott-benzonatate-capsules-recall-label-mix-up-risk. Based on FDA recall #D-1124-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1124-2022%22&limit=1).
The FDA announced on Jan. 15, 2021, that Calvin Scott & Company, Inc. is recalling Benzonatate capsules and Benzphetamine tablets due to a labeling mix-up, according to the FDA. The Class I recall involves 10 bottles distributed by Calvin Scott & Co., Inc. in Albuquerque, NM.
The recall addresses a labeling mix-up where bottles labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets, and vice versa. The FDA classified this hazard as Class I.
Context
GovInfoNow's records show Calvin Scott & Company, Inc. has two other recalls on record since July 27, 2020. On Sept. 16, 2020, the company issued a recall for Diethylpropion Tablets due to repackaging without stability studies. On July 27, 2020, Calvin Scott recalled Phentermine Capsules because light-sensitive drugs were repackaged in transparent pouches. Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (Aug. 19, 2026) and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026).
How to tell if you have this one
Check for Benzonatate 100mg capsules repackaged in 30-count bottles with NDC 67877-0573-05 and CSI Lot: CS-20180W-004, expiring 3/22.
Brand
Calvin Scott
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Status
Terminated
Distribution
1 physician in Alpharetta, GA
Recall number
Product, codes & lots
Quantity
Class
D-1123-2022
Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50; CSI Lot: CS-20274-005, Exp 5/22
13 bottles
Class III
D-1124-2022
Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 67877-0573-05; CSI Lot: CS-20180W-004, Exp 3/22
10 bottles
Class I
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the label mix-up: bottles labeled as Benzonatate 100mg capsules may contain Benzphetamine 50mg tablets.
Where it went and when
Where it was distributed
Distributed in Georgia.
Listed by the agency
Not listed
FDA distribution: “1 physician in Alpharetta, GA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Georgia.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1124-2022 (January 15, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1124-2022 to see it in context.
Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.